These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 30420902)
1. The Evaluation of the Relationship between sTREM-1, VEGF-B, and VEGF Gene Expression Levels with Disease Activity of Behçet's Patients. Harmanci K; Akan OY; Pirildar T; Ortan P; Ulman C Dis Markers; 2018; 2018():2649392. PubMed ID: 30420902 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202 [TBL] [Abstract][Full Text] [Related]
3. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis. Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882 [TBL] [Abstract][Full Text] [Related]
4. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease. Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524 [TBL] [Abstract][Full Text] [Related]
5. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease. Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175 [TBL] [Abstract][Full Text] [Related]
6. Correlation between soluble triggering receptor expressed on myeloid cells-1 and endoscopic activity in intestinal Behçet's disease. Lee HJ; Shin HS; Jang HW; Kim SW; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH Yonsei Med J; 2014 Jul; 55(4):960-6. PubMed ID: 24954324 [TBL] [Abstract][Full Text] [Related]
7. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease. Gheita TA; Sakr BR; Rabea RE; Abd ElHamid SM Clin Rheumatol; 2019 Aug; 38(8):2201-2210. PubMed ID: 30919148 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis. Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763 [TBL] [Abstract][Full Text] [Related]
9. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease. Kamoun M; Houman MH; Hamzaoui A; Hamzaoui K Tissue Antigens; 2008 Dec; 72(6):581-7. PubMed ID: 19054372 [TBL] [Abstract][Full Text] [Related]
11. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease. Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285 [TBL] [Abstract][Full Text] [Related]
12. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience. Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease. Oztürk MA; Unverdi S; Oktar SO; Bukan N; Gülbahar O; Ureten K; Göker B; Haznedaroglu S; Sungur G; Ciftçi TU; Onat AM Clin Rheumatol; 2008 Aug; 27(8):961-6. PubMed ID: 18204875 [TBL] [Abstract][Full Text] [Related]
14. High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behçet's disease and their relationship to disease activity. Arica DA; Akşan B; Örem A; Altinkaynak BA; Yayli S; Sönmez M An Bras Dermatol; 2019 Jul; 94(3):320-326. PubMed ID: 31365661 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet's disease patients. Ibrahim W; Sakr BR; Obaya E; Ghonem H Clin Rheumatol; 2019 Feb; 38(2):397-402. PubMed ID: 29987428 [TBL] [Abstract][Full Text] [Related]
16. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease? Atıl A; Deniz A Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007 [TBL] [Abstract][Full Text] [Related]
17. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet's Disease in Iranian Population. Shahriyari E; Bonyadi M; Jabbarpoor Bonyadi MH; Soheilian M; Yaseri M; Ebrahimiadib N Curr Eye Res; 2019 Feb; 44(2):200-205. PubMed ID: 30289285 [TBL] [Abstract][Full Text] [Related]
19. VEGF and mRNA VEGF expression in CSF from Behçet's disease with neurological involvement. Hamzaoui K; Ayed K; Hamza M; Hamzaoui A J Neuroimmunol; 2009 Aug; 213(1-2):148-53. PubMed ID: 19493574 [TBL] [Abstract][Full Text] [Related]
20. Clinical profiling, treatment characteristics and outcome in Behcet's Disease (BD)-A retrospective cohort study from Karnataka Rheumatology Association (KRA). Rao VK; Kodali RS; Patil A; Chebbi P; Subramanian R; Kumar S; Singh YP; Chandrashekara S; Shobha V Clin Rheumatol; 2024 Oct; 43(10):3223-3230. PubMed ID: 39096360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]